Search research articles
Contact Us
Filters
Showing results (31-40 of 137) with videos related to
Page
of 14
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
March 8, 2022
Disease and Clinical Characteristics of Patients With a Clinical Diagnosis of Myelofibrosis Enrolled in the MOST Study
Aaron T Gerds, Roger M Lyons, Philomena Colucci, et al.
Journal of Medical Economics
|
June 9, 2023
Ruxolitinib for myelofibrosis in elderly non-transplant patients: healthcare resource utilization and costs
Aaron T Gerds, Jingbo Yu, Anne Shah, et al.
Leukemia & Lymphoma
|
January 5, 2026
Pharmacy and transfusion costs of ruxolitinib and momelotinib in patients with myelofibrosis and anemia
Aaron T Gerds, Jingbo Yu, Charles Tao, et al.
Journal of Managed Care & Specialty Pharmacy
|
October 3, 2024
Evaluating estimated health care resource utilization and costs in patients with myelofibrosis based on transfusion status and anemia severity: A retrospective analysis of the Medicare Fee-For-Service claims data
Aaron T Gerds, Joseph Tkacz, Laura Moore-Schiltz, et al.
Journal of Comparative Effectiveness Research
|
August 2, 2023
Cost-effectiveness of ropeginterferon alfa-2b-njft for the treatment of polycythemia vera
Aaron T Gerds, Claudia Castro, Frank Snopek, et al.
Leukemia Research
|
June 14, 2025
A phase 2 study of itacitinib alone or in combination with low-dose ruxolitinib in patients with myelofibrosis
Moshe Talpaz, Aaron T Gerds, Roger Lyons, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 19, 2012
Pretransplantation therapy with azacitidine vs induction chemotherapy and posttransplantation outcome in patients with MDS
Aaron T Gerds, Ted A Gooley, Elihu H Estey, et al.
Leukemia Research
|
February 27, 2022
Thrombotic events and mortality risk in patients with newly diagnosed polycythemia vera or essential thrombocythemia
Naveen Pemmaraju, Aaron T Gerds, Jingbo Yu, et al.
Acta Haematologica
|
January 10, 2022
Ruxolitinib Re-Treatment in Patients with Myelofibrosis: Real-World Evidence on Patient Characteristics and Outcomes
Aaron T Gerds, Jingbo Yu, Robyn M Scherber, et al.
Hemasphere
|
October 7, 2022
Treating Anemic Patients With Myelofibrosis in the New Janus Kinase Inhibitor Era: Current Evidence and Real-world Implications
Aaron T Gerds, Prithviraj Bose, Gabriela S Hobbs, et al.
Page
of 14
Search research articles
Search
Showing results (31-40 of 137) with videos related to
Sort By:
Page
of 14
Clinical Lymphoma, Myeloma & Leukemia
|
March 8, 2022
Disease and Clinical Characteristics of Patients With a Clinical Diagnosis of Myelofibrosis Enrolled in the MOST Study
Aaron T Gerds, Roger M Lyons, Philomena Colucci, et al.
Journal of Medical Economics
|
June 9, 2023
Ruxolitinib for myelofibrosis in elderly non-transplant patients: healthcare resource utilization and costs
Aaron T Gerds, Jingbo Yu, Anne Shah, et al.
Leukemia & Lymphoma
|
January 5, 2026
Pharmacy and transfusion costs of ruxolitinib and momelotinib in patients with myelofibrosis and anemia
Aaron T Gerds, Jingbo Yu, Charles Tao, et al.
Journal of Managed Care & Specialty Pharmacy
|
October 3, 2024
Evaluating estimated health care resource utilization and costs in patients with myelofibrosis based on transfusion status and anemia severity: A retrospective analysis of the Medicare Fee-For-Service claims data
Aaron T Gerds, Joseph Tkacz, Laura Moore-Schiltz, et al.
Journal of Comparative Effectiveness Research
|
August 2, 2023
Cost-effectiveness of ropeginterferon alfa-2b-njft for the treatment of polycythemia vera
Aaron T Gerds, Claudia Castro, Frank Snopek, et al.
Leukemia Research
|
June 14, 2025
A phase 2 study of itacitinib alone or in combination with low-dose ruxolitinib in patients with myelofibrosis
Moshe Talpaz, Aaron T Gerds, Roger Lyons, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 19, 2012
Pretransplantation therapy with azacitidine vs induction chemotherapy and posttransplantation outcome in patients with MDS
Aaron T Gerds, Ted A Gooley, Elihu H Estey, et al.
Leukemia Research
|
February 27, 2022
Thrombotic events and mortality risk in patients with newly diagnosed polycythemia vera or essential thrombocythemia
Naveen Pemmaraju, Aaron T Gerds, Jingbo Yu, et al.
Acta Haematologica
|
January 10, 2022
Ruxolitinib Re-Treatment in Patients with Myelofibrosis: Real-World Evidence on Patient Characteristics and Outcomes
Aaron T Gerds, Jingbo Yu, Robyn M Scherber, et al.
Hemasphere
|
October 7, 2022
Treating Anemic Patients With Myelofibrosis in the New Janus Kinase Inhibitor Era: Current Evidence and Real-world Implications
Aaron T Gerds, Prithviraj Bose, Gabriela S Hobbs, et al.
Page
of 14